Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-11898143-B2 United States of America 13 Feb 2024
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular… Grant US-11844843-B2 United States of America 19 Dec 2023
Muscle-targeting complex comprising an anti-transferrin receptor antibody linked to an… Grant US-11795233-B2 United States of America 24 Oct 2023
Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor… Grant US-11795234-B2 United States of America 24 Oct 2023
Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject… Grant US-11787869-B2 United States of America 17 Oct 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular… Grant US-11759525-B1 United States of America 19 Sep 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular… Grant US-11679161-B2 United States of America 20 Jun 2023
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular… Grant US-11638761-B2 United States of America 02 May 2023
Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular… Grant US-11518816-B2 United States of America 06 Dec 2022
Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes… Grant US-11390682-B2 United States of America 19 Jul 2022
Complex comprising anti-transferrin receptor antibody covalently linked to an… Grant US-11286305-B2 United States of America 29 Mar 2022
AGENTS FOR USE IN TREATING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD) Grant EP-3636778-B1 European Patent Office 12 Jan 2022
Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin… Grant US-11111309-B2 United States of America 07 Sep 2021
Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-10907157-B2 United States of America 02 Feb 2021
Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule… Grant US-10865445-B2 United States of America 15 Dec 2020
NUCLEIC ACID AGENTS FOR USE IN TREATING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD) Grant EP-3192880-B1 European Patent Office 09 Oct 2019
Agents useful in treating facioscapulohumeral muscular dystrophy Grant US-9988628-B2 United States of America 05 Jun 2018
AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY Application EP-3118316-A1 European Patent Office 18 Jan 2017
Agents useful in treating facioscapulohumeral muscular dystrophy Application EP-2426203-A3 European Patent Office 14 Mar 2012